Vision Monday


Dr. Brian Marr Named Director of Ophthalmic Oncology at NewYork-Presbyterian/Columbia Medical Center

By Staff
Wednesday, May 24, 2017 12:15 AM

Dr. Brian Marr.

NEW YORK—Dr. Brian Marr will join the department of ophthalmology at NewYork-Presbyterian/Columbia University Medical Center as director of the division of ophthalmic oncology, effective May 15. He will also serve as a professor of ophthalmology at Columbia University Medical Center, according to an announcement from the Medical Center.

With Dr. Marr’s arrival, the Medical Center is establishing one of the largest and most comprehensive ocular melanoma programs in the country, the announcement said. Dr. Marr will be working alongside medical oncologists, in keeping with NewYork-Presbyterian/Columbia University Medical Center’s team-based approach to cancer care. Prior to joining NewYork-Presbyterian/Columbia, he worked at Memorial Sloan-Kettering Cancer Center.

“Dr. Marr is a renowned leader in the diagnosis, treatment and management of eye cancers, and we are pleased to welcome him to NewYork-Presbyterian/Columbia University Medical Center,” said Dr. George A. “Jack” Cioffi, the Edward S. Harkness chairman of the Department of Ophthalmology and ophthalmologist-in-chief at New York-Presbyterian/Columbia University Medical Center.

As one of the few ocular oncologists trained in all aspects of eye cancers, Dr. Marr’s clinical experience in treating these diseases is among the most extensive in the world. He has devised and performed thousands of surgical procedures on tumors of the eye, eyelid, orbit and conjunctiva in adults, children and infants, and is one of the few surgeons experienced in intraocular tumor resection, as well as advanced laser, radiation and chemotherapy treatments.

A board-certified ophthalmologist, Dr. Marr is a member of the American Medical Association and a board-certified fellow of the American Academy of Ophthalmology, for which he has lectured frequently. He was recognized as one of New York Magazine’s “Top Doctors” from 2014 to 2016.
Also Recommended
Shire’s Board Says its ‘Willing to Recommend’ Revised Offer from Takeda Pharmaceutical
Pearle Vision Partners with Cincinnati Children’s Hospital to Open Campus Location
Robert Marc to Exit Robert Marc Eyewear
Safilo Group’s Newly Elected Board of Directors Confirms Trocchia as CEO
Home VM Mobile